aTyr Pharma reported 69.82M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Ardelyx USD 5.6M 160K Mar/2026
aTyr Pharma 69.82M 9.83M Jun/2026
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 407M 4M Jun/2026
Cipla INR 170.3M 39M Jun/2026
Compugen USD 1.35M 399K Mar/2026
CSL USD 215M 111M Dec/2025
Curis USD 178K 441K Dec/2023
GlaxoSmithKline GBP 121M 46M Jun/2026
Grifols EUR 156.07M 31.46M Sep/2025
Lakefront Biotherapeutics EUR 1.72M 940K Sep/2025
Novartis USD 462M 119M Jun/2026
Roche Holding CHF 304M 7.5M Jun/2025
United Therapeutics USD 2.9M 200K Jun/2026